selected scholarly activity
-
chapters
- An international perspective on the basis of pay-for-performance. 147-155. 2018
- The contribution of primary care research to improving health services. 67-72. 2016
- Does My Bias Look Big in This?. Research Ethics Forum. 197-208. 2016
- A Primary Care Perspective on Prescribing for Women. 403-432. 2015
- Clinical Care and Health Disparities. Annual Review of Public Health. 89-106. 2012
-
conferences
- GERAS FRAILTY REHABILITATION AT HOME RANDOMIZED CONTROLLED TRIAL: VIRTUAL BUNDLED CARE FOR SENIORS WHO ARE FRAIL TO BUILD STRENGTH AND RESILIENCE DURING COVID-19. Aging - Clinical and Experimental Research. S52-S52. 2022
- Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study. Pharmacoepidemiology and Drug Safety. 76-76. 2022
- IMPACT OF DEPRESSION RELAPSE ON PARTICIPANT QUALITY OF LIFE AND COSTS TO THE ENGLISH NHS: SECONDARY ANALYSIS FROM THE ANTLER STUDY ON ANTIDEPRESSANT DISCONTINUATION IN WELL PATIENTS IN PRIMARY CARE. Value in Health. S375-S375. 2022
- Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared to Long-Term Maintenance: the ANTLER Study. Journal of Mental Health Policy and Economics. S7-S7. 2022
- Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study. Pharmacoepidemiology and Drug Safety. 33-34. 2021
- Engaging general practice and patients with AusTAPER, a pharmacist facilitated web‐based deprescribing tool. Journal of Pharmacy Practice and Research. 154-159. 2021
- Nortriptyline in Knee Arthritis (Nortika): A Randomised Controlled Double Blind Trial of Nortriptyline for Pain in Knee Osteoarthritis. Arthritis & Rheumatology. 2019
- To be successful or not to be: retrospective analysis of two deprescribing case studies. Journal of The American Geriatrics Society. S185-S185. 2019
- Is Hospital in the Home a good option for older people?. Journal of The American Geriatrics Society. 7-7. 2010
-
journal articles
- The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) hospital study: effect of a collaborative medication review on the number of current regular medicines for older hospital inpatients.. Internal Medicine Journal. 54:1719-1732. 2024
- Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence.. Epidemiology and Psychiatric Sciences. 33:e40. 2024
- Cost-effectiveness analysis of health tapestry, a complex primary care program for older adults: a post-hoc analysis. BMC Primary Care. 25:235. 2024
- Describing primary care patterns before and during the COVID-19 pandemic across Canada: a quasi-experimental pre–post design cohort study using national practice-based research network data. BMJ Open. 14:e084608-e084608. 2024
- The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand. Value in Health Regional Issues. 41:72-79. 2024
- Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review. The Lancet Healthy Longevity. 5:e287-e296. 2024
- Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis. Journal of the American Medical Directors Association. 25:539-544.e2. 2024
- Drug and Natural Health Product Data Collection and Curation in the Canadian Longitudinal Study on Aging – ADDENDUM. Canadian Journal on Aging. 1-1. 2024
- Drug and Natural Health Product Data Collection and Curation in the Canadian Longitudinal Study on Aging. Canadian Journal on Aging. 1-7. 2024
- Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: Reflections and recommendations. Basic and Clinical Pharmacology and Toxicology. 134:121-125. 2024
- The association between patients’ frailty status, multimorbidity, and demographic characteristics and changes in primary care for chronic conditions during the COVID-19 pandemic: a pre-post study. Family Practice. 40:523-530. 2023
- Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Drugs and Aging. 40:857-868. 2023
- Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial. The journals of gerontology. Series A, Biological sciences and medical sciences. 78:1692-1700. 2023
- Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults. Journal of the American Medical Directors Association. 24:1253-1260. 2023
- Effects of the COVID-19 Pandemic on Primary Health Care for Chronic Conditions in Canada: Protocol for a Retrospective Pre-Post Study Using National Practice-Based Research Network Data. JMIR Research Protocols. 12:e49131-e49131. 2023
- Understanding collaborative implementation between community and academic partners in a complex intervention: a qualitative descriptive study. BMC Health Services Research. 23:606. 2023
- Tolerability of bedtime diuretics: a prospective cohort analysis. BMJ Open. 13:e068188-e068188. 2023
- Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy. Pilot and Feasibility Studies. 9:84. 2023
- Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study. Age and Ageing. 52:afad081. 2023
- A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing. Medical Science Educator. 33:551-567. 2023
- Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation. Archives of gerontology and geriatrics. Supplement. 107:104910-104910. 2023
- Health TAPESTRY Ontario: A Multi-Site Randomized Controlled Trial Testing Implementation and Reproducibility. Annals of Family Medicine. 21:132-142. 2023
- Association between frailty, chronic conditions and socioeconomic status in community-dwelling older adults attending primary care: a cross-sectional study using practice-based research network data. BMJ Open. 13:e066269-e066269. 2023
- Polypharmacy and medicine regimens in older adults in residential aged care. Archives of gerontology and geriatrics. Supplement. 105:104849-104849. 2023
- Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway. Journal of Patient Experience. 10:237437352311747-237437352311747. 2023
- The implementation and validation of the NoMAD during a complex primary care intervention. BMC Medical Research Methodology. 22:175. 2022
- Understanding how context and culture in six communities can shape implementation of a complex intervention: a comparative case study. BMC Health Services Research. 22:221. 2022
- Understanding volunteer retention in a complex, community‐centred intervention: A mixed methods study in Ontario, Canada. Health and Social Care in the Community. 30:2259-2269. 2022
- Correction: Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review. BMC Medicine. 20:401. 2022
- Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review. Systematic Reviews. 11:225. 2022
- Recommendations for outcome measurement for deprescribing intervention studies. Journal of The American Geriatrics Society. 70:2487-2497. 2022
- Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review. BMC Medicine. 20:297. 2022
- Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technology Assessment. 26:1-148. 2022
- EE214 Impact of Depression Relapse on Participant Quality of Life and Costs to the English NHS: Secondary Analysis from the Antler Study on Antidepressant Discontinuation in Well Patients in Primary Care. Value in Health. 25:S375-S375. 2022
- Interventions to address polypharmacy in older adults living with multimorbidity. Canadian Family Physician. 68:e215-e226. 2022
- Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug Safety. 45:623-638. 2022
- Lessons Learned Through Two Phases of Developing and Implementing a Technology Supporting Integrated Care: Case Study. JMIR Formative Research. 6:e34899-e34899. 2022
- Community Volunteers and Primary Care Providers Supporting Older Adults in System Navigation: A Mixed Methods Study. International Journal of Integrated Care. 22:18. 2022
- Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study. Applied Health Economics and Health Policy. 20:269-282. 2022
- Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality and Safety. 31:179-190. 2022
- Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants. Pharmaceuticals Policy and Law. 33:37-47. 2022
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Pharmaceuticals Policy and Law. 33:65-76. 2022
- Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial. BMJ Open. 12:e059711-e059711. 2022
- POS-314 POLYPHARMACY AND POTENTIALLY INAPPROPRIATE MEDICATION USE IN PATIENTS WITH CKD MANAGED IN CANADIAN PRIMARY CARE. Kidney International Reports. 7:S141-S141. 2022
- POS-315 PREVALENCE OF POLYPHARMACY AND ASSOCIATED ADVERSE HEALTH OUTCOMES IN PATIENTS WITH CKD: A SYSTEMATIC REVIEW AND META-ANALYSIS. Kidney International Reports. 7:S141-S142. 2022
- Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community. Trials. 22:766. 2021
- Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis. Systematic Reviews. 10:198. 2021
- Strategies for working across Canadian practice-based research and learning networks (PBRLNs) in primary care: focus on frailty. BMC Primary Care. 22:220. 2021
- Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial. Trials. 22:746. 2021
- Lessons Learned Through Two Phases of Developing and Implementing a Technology Supporting Integrated Care: Case Study (Preprint) 2021
- Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Health Technology Assessment. 25:1-62. 2021
- Polypharmacy and Potentially Inappropriate Medication Use in Patients with CKD Managed in Canadian Primary Care. Journal of the American Society of Nephrology. 32:697-697. 2021
- Prevalence of Polypharmacy and Associated Adverse Health Outcomes in Patients with CKD: A Systematic Review and Meta-Analysis. Journal of the American Society of Nephrology. 32:734-734. 2021
- Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine. 385:1257-1267. 2021
- The use of inhaled corticosteroids in early-stage COVID-19. The Lancet. 398:818-819. 2021
- Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practice. British Journal of General Practice. 71:e538-e546. 2021
- Deprescribing Antidepressants in Older People ‐ Breaking Up Can Be Hard to Do. The Senior care pharmacist. 36:228-237. 2021
- Machine learning for identification of frailty in Canadian primary care practices. International Journal of Population Data Science. 6:1650. 2021
- Disconnected relationships between primary care and community-based health and social services and system navigation for older adults: a qualitative descriptive study. BMC Primary Care. 21:69. 2020
- Examining Interprofessional teams structures and processes in the implementation of a primary care intervention (Health TAPESTRY) for older adults using normalization process theory. BMC Primary Care. 21:63. 2020
- Health TAPESTRY Ontario: protocol for a randomized controlled trial to test reproducibility and implementation. Trials. 21:714. 2020
- Polypharmacy and mobility outcomes. Mechanisms of Ageing and Development. 192:111356-111356. 2020
- Delphi consensus on core criteria set selecting among health-related outcome measures (HROM) in primary health care. Journal of Clinical Epidemiology. 127:105-116. 2020
- Strategies to Mitigate Anxiety and Pain in Intrauterine Device Insertion: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 42:1138-1146.e2. 2020
- Embedding “Smart” Disease Coding Within Routine Electronic Medical Record Workflow: Prospective Single-Arm Trial. JMIR Medical Informatics. 8:e16764-e16764. 2020
- Health TAPESTRY Ontario: Protocol for a Randomized Controlled Trial to Test Reproducibility and Implementation 2020
- Exploration of volunteers as health connectors within a multicomponent primary care‐based program supporting self‐management of diabetes and hypertension. Health and Social Care in the Community. 28:734-746. 2020
- Health TAPESTRY Ontario: Protocol for a Randomized Controlled Trial to Test Reproducibility and Implementation 2020
- The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system. Cochrane Database of Systematic Reviews. 2019. 2019
- Health TAPESTRY Ontario: Protocol for a Randomized Controlled Trial to Test Replicability and Implementation 2019
- A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial. Trials. 20:319. 2019
- Pilot randomized controlled trial of a complex intervention for diabetes self-management supported by volunteers, technology, and interprofessional primary health care teams. Pilot and Feasibility Studies. 5:118. 2019
- Embedding “Smart” Disease Coding Within Routine Electronic Medical Record Workflow: Prospective Single-Arm Trial (Preprint) 2019
- Clinical judgments, not algorithms, are key to patient safety—an essay by David Healy and Dee Mangin. The BMJ. 367:l5777-l5777. 2019
- Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals. Pharmaceuticals Policy and Law. 30:167-178. 2019
- Quality of Chronic Kidney Disease Management in Canadian Primary Care. JAMA network open. 2:e1910704-e1910704. 2019
- Multimorbidity Frameworks Impact Prevalence and Relationships with Patient‐Important Outcomes. Journal of The American Geriatrics Society. 67:1632-1640. 2019
- Perceptions of older adults in Ontario, Canada on the implementation and impact of a primary care programme, Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY): a descriptive qualitative study. BMJ Open. 9:e026257-e026257. 2019
- Pill for this and a pill for that: A cross‐sectional survey of use and understanding of medication among adults with multimorbidity. Australasian Journal on Ageing. 38:91-97. 2019
- Combining volunteers and primary care teamwork to support health goals and needs of older adults: a pragmatic randomized controlled trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 191:E491-E500. 2019
- Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study. Kidney International Reports. 4:561-570. 2019
- Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: a population-based clustered multiple baseline time series design. BMJ Open. 9:e022984-e022984. 2019
- DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. International Journal of Clinical Pharmacy. 41:167-178. 2019
- Multimorbidity, eHealth and implications for equity: a cross-sectional survey of patient perspectives on eHealth. BMJ Open. 9:e023731-e023731. 2019
- Gabapentin misuse. CANADIAN MEDICAL ASSOCIATION JOURNAL. 191:E47-E47. 2019
- Demonstrating a Technology-Mediated Intervention to Support Medication Adherence in Community-Dwelling Older Adults in Primary Care: A Feasibility Study. Gerontology and Geriatric Medicine. 5:233372141984517-233372141984517. 2019
- Deprescribing Is an Essential Part of Good Prescribing.. American Family Physician. 99:7-9. 2019
- Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use. Therapeutic Advances in Drug Safety. 10:204209861988315-204209861988315. 2019
- ‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety. Therapeutic Advances in Drug Safety. 10:204209861983879-204209861983879. 2019
- Feasibility study of goal setting discussions between older adults and volunteers facilitated by an eHealth application: development of the Health TAPESTRY approach. Pilot and Feasibility Studies. 4:184. 2018
- GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647). Pilot and Feasibility Studies. 4:116. 2018
- Protocol for a Delphi consensus exercise to identify a core set of criteria for selecting health related outcome measures (HROM) to be used in primary health care. BMC Primary Care. 19:152. 2018
- Legacy Drug-Prescribing Patterns in Primary Care. Annals of Family Medicine. 16:515-520. 2018
- International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action. Drugs and Aging. 35:575-587. 2018
- The impact of multimorbidity on people's lives: a cross-sectional survey.. Proceedings of the University of Otago Medical School. 131:78-90. 2018
- Citizen petition: Sexual side effects of SSRIs and SNRIs. Pharmaceuticals Policy and Law. 29:135-147. 2018
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. Pharmaceuticals Policy and Law. 29:125-134. 2018
- Clinical guidelines: what happens when people have multiple conditions?. Proceedings of the University of Otago Medical School. 131:73-81. 2018
- Effect of multimorbidity on health service utilisation and health care experiences. Journal of Primary Health Care. 10:44-44. 2018
- Self-efficacy for medication management: a systematic review of instruments. Patient Preference and Adherence. Volume 12:1279-1287. 2018
- Developing and testing an electronic medication administration monitoring device for community dwelling seniors: a feasibility study. Pilot and Feasibility Studies. 3:5. 2017
- Do Residents Need All Their Medications? A Cross-Sectional Survey of RNs' Views on Deprescribing and the Role of Clinical Pharmacists. Journal of Gerontological Nursing. 43:13-20. 2017
- A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol. BMJ Open. 7:e016267-e016267. 2017
- A META-ANALYSIS OF HOSPITAL IN THE HOME. Innovation in Aging. 1:1246-1246. 2017
- CAN DEPRESCRIBING GIVE WHAT POLYPHARMACY HAS TAKEN AWAY? FEASIBILITY TRIAL IN RESIDENTIAL AGED CARE. Innovation in Aging. 1:588-589. 2017
- DO MY PATIENTS NEED ALL THEIR MEDICINES? REGISTERED NURSES’ VIEWS ON DEPRESCRIBING. Innovation in Aging. 1:571-571. 2017
- A walking stick in one hand and a chainsaw in the other: patients' perspectives of living with multimorbidity.. Proceedings of the University of Otago Medical School. 130:65-76. 2017
- Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities. BMJ Open. 7:e013800-e013800. 2017
- Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?. Proceedings of the University of Otago Medical School. 130:94-101. 2017
- A healthy lifestyle app for older adults with diabetes and hypertension: usability assessment. International Journal of Healthcare Technology and Management. 16:250-250. 2017
- A healthy lifestyle app for older adults with diabetes and hypertension: usability assessment. International Journal of Healthcare Technology and Management. 16:250-250. 2017
- Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence. Pharmaceuticals Policy and Law. 28:125-141. 2016
- Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open. 6:e010903-e010903. 2016
- Abstracts: Scientific papers, education sessions to be presented at the May 26–28, 2016 Victoria, BC. Physiotherapy Canada. Physiotherapie Canada. 68:1-63. 2016
- General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study. International Journal of Clinical Practice. 70:261-276. 2016
- Challenges and Enablers of Deprescribing: A General Practitioner Perspective. PLoS ONE. 11:e0151066-e0151066. 2016
- A protocol for a pragmatic randomized controlled trial using the Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY) platform approach to promote person-focused primary healthcare for older adults. Implementation Science. 11:49. 2015
- Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial. Trials. 16:448. 2015
- The art and science of marketing medications.. Proceedings of the University of Otago Medical School. 128:11-12. 2015
- Horses and buggies have some advantages over cars, but no one is turning back.. Canadian Family Physician. 61:416-419. 2015
- The shipwreck of the singular. Social Studies of Science. 44:518-523. 2014
- Ethical issues related to health checks.. The BMJ. 349:g4787. 2014
- Ninety-three cases of alcohol dependence following SSRI treatment. Pharmaceuticals Policy and Law. 26:99-107. 2014
- One hundred and twenty cases of enduring sexual dysfunction following treatment. Pharmaceuticals Policy and Law. 26:109-116. 2014
- Sudden cardiac death & The Reverse Dodo Verdict. Pharmaceuticals Policy and Law. 26:71-79. 2014
- The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study. BMJ Open. 3:e003475-e003475. 2013
- Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers. British Journal of General Practice. 63:e416-e422. 2013
- Commentary. Annals of Internal Medicine. 158. 2013
- Data based medicine and clinical judgement. Pharmaceuticals Policy and Law. 25:111-121. 2013
- A meta‐analysis of “hospital in the home”. Medical Journal of Australia. 197:512-519. 2012
- Direct-to-consumer genetic testing: letting the genie out of the bottle?. Proceedings of the University of Otago Medical School. 125:7-10. 2012
- Beyond diagnosis: rising to the multimorbidity challenge.. The BMJ. 344:e3526. 2012
- Back to Back: Adherence to evidence-based guidelines is the key to improved health outcomes for general practice patients: No. Journal of Primary Health Care. 4:158-158. 2012
- Chlamydia trachomatis Testing Sensitivity in Midstream Compared With First-Void Urine Specimens. Annals of Family Medicine. 10:50-53. 2012
- Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women. Obstetrics and Gynecology. 118:708-708. 2011
- Paroxetine is associated with malformation during pregnancy.. The BMJ. 343:d5060. 2011
- Risk communication methods in hip fracture prevention: a randomised trial in primary care. British Journal of General Practice. 61:e469-e476. 2011
- Reducing Polypharmacy: Is Hospitalization the Right Time?—Reply. JAMA Internal Medicine. 171:869-869. 2011
- The future of national health systems. British Journal of General Practice. 61:319-320. 2011
- Can general practitioners provide effective cardiovascular disease (CVD) prevention? Dreams and realities of CVD prevention.. Proceedings of the University of Otago Medical School. 124:72-81. 2011
- Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults. JAMA Internal Medicine. 170:1648-1654. 2010
- Urinary tract infection in primary care. The BMJ. 340:c657-c657. 2010
- An international perspective on the basis for payment for performance.. Journal of Clinical Excellence. 18:399-404. 2010
- Back to Back: All people over 75 years with a five-year CVD risk of ≥ 15% should be treated with statins unless specifically contraindicated: No. Journal of Primary Health Care. 2:333-333. 2010
- Letter to the Editor. Journal of Veterinary Internal Medicine (JVIM). 24:7-7. 2010
- The ethics of randomized placebo controlled trials of antidepressants with pregnant women. Pharmaceuticals Policy and Law. 22:7-16. 2010
- To the Editor. Hastings Center Report. 40:7-7. 2010
- Opinion: Direct-To-Consumer Advertising of Prescription Medicines: A Counter Argument. Future Medicinal Chemistry. 1:1555-1560. 2009
- Should we give aspirins and statins to the elderly?. Journal of Primary Health Care. 1:338. 2009
- Should we give aspirins and statins to the elderly?. Journal of Primary Health Care. 1:338-339. 2009
- Women should give informed consent before starting SSRIs.. The BMJ. 339:b4292. 2009
- A dipstick clinical prediction rule modestly improved diagnostic precision in women with suspected urinary tract infection. BMJ Evidence-Based Medicine. 14:155-155. 2009
- Commentary: The Once and Future Psychiatry. Academic Medicine. 84:418-420. 2009
- Evidence of net benefit is lacking. The BMJ. 335:1170. 2007
- The slippery slope to New Zealand. The BMJ. 335:0712438-0712438. 2007
- Industry funded patient information and the slippery slope to New Zealand. The BMJ. 335:694-695. 2007
- Preventive health care in elderly people needs rethinking. The BMJ. 335:285-287. 2007
- The Quality and Outcomes Framework: what have you done to yourselves?. British Journal of General Practice. 57:435-437. 2007
- Urinary tract infection in primary care. The BMJ. 334:597-598. 2007
- Diabetes care in rest homes in Christchurch, New Zealand. Diabetic Medicine. 23:1252-1256. 2006
- Management of uncertainty. The BMJ. 333:693-693. 2006
- The impact of advertising prescription medicines directly to consumers in New Zealand: lessons for Australia. Australian Prescriber. 29:30-32. 2006
- In reply [7]. Medical Journal of Australia. 184:143. 2006
- Safety of hospital in the home. Medical Journal of Australia. 184:143-143. 2006
- Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?. Proceedings of the University of Otago Medical School. 118:U1726. 2005
- Home management of mild to moderately severe community‐acquired pneumonia: a randomised controlled trial. Medical Journal of Australia. 183:235-238. 2005
- Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. The BMJ. 331:143-146B. 2005
- Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. The BMJ. 331:143-143. 2005
- Response to Maubach and Hoek's paper on GP attitudes to DTCA (multiple letters) [4]. New Zealand Medical Journal. 118. 2005
- Response to Maubach and Hoek's paper on GP attitudes to DTCA.. Proceedings of the University of Otago Medical School. 118:U1543. 2005
- Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. The BMJ. 330:129-129. 2005
- Direct to consumer advertising. The BMJ. 330:5-6. 2005
- Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.. Proceedings of the University of Otago Medical School. 117:U905. 2004
- New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?. Proceedings of the University of Otago Medical School. 116:U556. 2003
- Improving the effectiveness of smoking cessation in primary care: lessons learned.. Proceedings of the University of Otago Medical School. 116:U417. 2003
- Do clinical practice education groups result in sustained change in GP prescribing?. Family Practice. 20:199-206. 2003
- The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'.. British Journal of General Practice. 53:342-345. 2003
- DTCA in New Zealand: the challenge of finding an acceptable balance.. British Journal of General Practice. 52:341. 2002
- Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories.. Proceedings of the University of Otago Medical School. 115:12-14. 2002
- Preventing cardiovascular disease in primary care. The BMJ. 323:246-247. 2001
- Manifesto de Curitiba: pela Prevenção Quaternária e por uma Medicina sem conflitos de interesse. Revista Brasileira de Medicina de Família e Comunidade. 9:371-374.
- Multimorbidity and Quaternary Prevention (P4). Revista Brasileira de Medicina de Família e Comunidade. 10:1-5.
-
preprints
- Drug and natural health product data collection and curation in the Canadian Longitudinal Study on Aging (CLSA) 2023
- Effects of the COVID-19 Pandemic on Primary Health Care for Chronic Conditions in Canada: Protocol for a Retrospective Pre-Post Study Using National Practice-Based Research Network Data (Preprint) 2023
- Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool 2023
- Interventions to Address Potentially Inappropriate Prescriptions and Over-The-Counter Medication Use Among Adults 65 Years and Older in Primary Care Settings: Protocol for a Systematic Review 2021
- Deprescribing To Reduce Polypharmacy: Study Protocol For A Randomised Controlled Trial Assessing Deprescribing of Anticholinergic and Sedative Drugs In A Cohort of Frail Older People Living In The Community 2021